KUALA LUMPUR: Health Minister Dr Zaliha Mustafa said the Health Ministry is still in a process of negotiating with Pfizer Sdn Bhd in regards to the Covid-19 bivalent vaccines.
said the Health Ministry is still in a process of negotiating with Pfizer Sdn Bhd in regards to the Covid-19 bivalent vaccines.
Dr Zaliha said this when asked by reporters on the update of the vaccine that was earlier estimated to arrive in Malaysia by the end of January. Meanwhile, on the event, Dr Zaliha said although positive progress has been achieved in cancer management, 63.7 per cent of all reported cancer cases were already in stages three and four when they were diagnosed.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Lima isu dibangkit sesi townhall bersama Dr. ZalihaIsu berkenaan termasuk isu doktor kontrak, penambahbaikan fasiliti kesihatan awam, kekurangan doktor di Jabatan Kecemasan.
Read more »
Trainee doctor, permanent post issues raised in dialogue with minister | The Malaysian InsightZaliha says she respects the views and will do her best to solve the problems.
Read more »
Rundingan vaksin bivalen dengan Pfizer masih berlangsung, kata menteri | The Malaysian InsightDr Zaliha Mustafa berkata beliau akan bertemu dengan syarikat itu dalam tempoh beberapa minggu lagi.
Read more »
Foreign minister: Malaysia, Arab Saudi agree to finalise institutional negotiations on coordinating councilPUTRAJAYA, Feb 22 — Malaysia and Saudi Arabia agreed to conclude negotiations immediately to institute the Saudi Arabia-Malaysia Coordination Council (SMCC), which will be the...
Read more »
Malaysia, Saudi Arabia agree to finalise SMCC negotiations, says ZambryPUTRAJAYA: Malaysia and Saudi Arabia agreed to conclude negotiations immediately to institute the Saudi Arabia-Malaysia Coordination Council (SMCC), which will be the main platform for bilateral cooperation in the future, says Foreign Minister Datuk Seri Dr Zambry Abd Kadir.
Read more »